Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Autran

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
[Development of an anti-HIV gene therapy based on the antiviral properties of beta interferon]E De Maeyer, V Vieillard, I Cremer, et al.
European Journal of Immunology|March 1, 1991
A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicityB Sadat-Sowti, P Debré, T Idziorek, et al.
Blood|April 21, 2001
HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patientsA Hosmalin, A Samri, M J Dumaurier, et al.
AIDS (London, England)|June 1, 1988
Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patientsB Autran, C M Mayaud, M Raphael, et al.
AIDS (London, England)|September 4, 1998
Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and proteaseG Haas, A Samri, E Gomard, et al.
Presse Medicale (Paris, France : 1983)|April 11, 1992
[Coronary pathology after heart transplantation]M Desruennes, G Drobinski, G Chomette, et al.
European Journal of Immunology|February 13, 2001
CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycleB Combadère, C Blanc, T Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skinN Delhem, F Hadida, G Gorochov, et al.
HIV Medicine|May 7, 2015
Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapyS Hattab, M Guiguet, G Carcelain, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|July 1, 1994
SCID-Hu mouse as a model for human lung HIV-1 infectionJ Y Cesbron, H Agut, B Gosselin, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
[Development of an anti-HIV gene therapy based on the antiviral properties of beta interferon]E De Maeyer, V Vieillard, I Cremer, et al.
European Journal of Immunology|March 1, 1991
A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicityB Sadat-Sowti, P Debré, T Idziorek, et al.
Blood|April 21, 2001
HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patientsA Hosmalin, A Samri, M J Dumaurier, et al.
AIDS (London, England)|June 1, 1988
Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patientsB Autran, C M Mayaud, M Raphael, et al.
AIDS (London, England)|September 4, 1998
Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and proteaseG Haas, A Samri, E Gomard, et al.
Presse Medicale (Paris, France : 1983)|April 11, 1992
[Coronary pathology after heart transplantation]M Desruennes, G Drobinski, G Chomette, et al.
European Journal of Immunology|February 13, 2001
CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycleB Combadère, C Blanc, T Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skinN Delhem, F Hadida, G Gorochov, et al.
HIV Medicine|May 7, 2015
Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapyS Hattab, M Guiguet, G Carcelain, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|July 1, 1994
SCID-Hu mouse as a model for human lung HIV-1 infectionJ Y Cesbron, H Agut, B Gosselin, et al.
Pageof 18